Evgen Revenue and Competitors

Wilmslow,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Evgen's estimated annual revenue is currently $1.6M per year.(i)
  • Evgen's estimated revenue per employee is $201,000

Employee Data

  • Evgen has 8 Employees.(i)
  • Evgen grew their employee count by -27% last year.

Evgen's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Business OfficerReveal Email/Phone
3
Development Project LeaderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Evgen?

Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products, addressing important clinical needs.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.6M

Revenue (est)

-27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Evgen News

2022-04-06 - VOA Exclusive: Ukraine Says Photos Show Russia Dug Trenches in Chernobyl’s Radioactive Soil

Evgen Kramarenko, director of the Ukrainian state agency managing the exclusion zone around the Chernobyl plant, sent the photos to VOA on...

2022-03-22 - Inside a volunteer effort to help Ukraine war refugees in Poland

Evgen Revun has lived half his life on the edge of a conflict zone. The Russian annexation of Crimea in 2014 and the subsequent proclamation of...

2022-02-22 - Evgen Pharma presents 2022 clinical trial plans and progress with US and UK regulators

Evgen Pharma PLC's (LON:EVG) Dr Huw Jones joins Proactive London to go through their portfolio with progress for is lead asset on two fronts in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.2M370%N/A
#2
$4.6M40N/AN/A
#3
$6.8M52N/AN/A
#4
$11.8M65-4%N/A
#5
$12.3M658%N/A